9SI Stock Chart & Stats
€226.00
-€4.00(-2.25%)
At close: 4:00 PM EST
€226.00
-€4.00(-2.25%)
Day’s Range― - ―
52-Week Range€137.00 - €308.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€3.23B
Enterprise Value€3.54K
Total Cash (Recent Filing)€103.72M
Total Debt (Recent Filing)€521.90M
Price to Earnings (P/E)36.9
Beta0.37
Next Earnings
Jul 30, 2026EPS Estimate
2.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.24
Shares Outstanding12,114,922
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-1.36
Price to Book (P/B)2.62
Price to Sales (P/S)2.36
P/FCF Ratio45.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€276.51Price Target Upside22.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)8.73
Revenue Forecast (FY)€825.95M
Bulls Say, Bears Say
Bulls Say
Diversified Engineered-products PortfolioStandex's multi-segment engineered-products model spreads end-market exposure across electronics, industrial, defense, scientific and engraving markets. That diversification supports steadier revenue streams, recurring aftermarket/service sales and resilience to single-market downturns, aiding multi-quarter stability.
Electronics Segment Strength And BacklogElectronics delivers scale and high margins with book-to-bill >1 and record quarterly revenue, indicating sustained demand and backlog conversion over coming quarters. Durable order strength in OEM electronics supports predictable production cadence and margin leverage versus commodity exposures.
Product Pipeline And Shift To Fast-growth MarketsA meaningful and accelerating new-product program plus targeted fast-growth end-market mix (~30% of sales guidance) create structural organic growth levers. New-product sales and portfolio repositioning should lift sustainable top-line growth and improve margin mix over mid-term periods.
Bears Say
High Absolute Debt And LeverageDespite recent paydown, the company still carries sizable absolute debt which increases interest costs and constrains financial flexibility for capex, dividends or acquisitions. Near‑2x leverage leaves less cushion versus adverse cycles and raises refinancing and covenant sensitivity risks over several quarters.
Weak Cash Conversion And Uneven FCFEarnings have not consistently converted to cash, with OCF roughly half of net income and FCF volatile. That reduces the company's ability to sustainably self-fund growth, repay debt or pursue acquisitions without relying on external financing or higher operating discipline over the medium term.
Segment Volatility And External Funding DependenceSegments tied to government or academic budgets and cyclical industrial markets show sensitivity to external funding and commodity cycles. NIH cuts and hydraulic-market softness highlight revenue volatility risks and make forward visibility on normalized margins and growth rates less certain across 2–6 months.
Standex International News
9SI FAQ
What was Standex International’s price range in the past 12 months?
Standex International lowest stock price was €137.00 and its highest was €308.00 in the past 12 months.
What is Standex International’s market cap?
Standex International’s market cap is €3.23B.
When is Standex International’s upcoming earnings report date?
Standex International’s upcoming earnings report date is Jul 30, 2026 which is in 4 days.
How were Standex International’s earnings last quarter?
Standex International released its earnings results on Apr 30, 2026. The company reported €1.941 earnings per share for the quarter, missing the consensus estimate of €1.946 by -€0.005.
Is Standex International overvalued?
According to Wall Street analysts Standex International’s price is currently Undervalued.
Does Standex International pay dividends?
Standex International does not currently pay dividends.
What is Standex International’s EPS estimate?
Standex International’s EPS estimate is 2.07.
How many shares outstanding does Standex International have?
Standex International has 12,114,922 shares outstanding.
What happened to Standex International’s price movement after its last earnings report?
Standex International reported an EPS of €1.941 in its last earnings report, missing expectations of €1.946. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Standex International?
Currently, no hedge funds are holding shares in DE:9SI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Standex International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€276.51 (22.35% Upside)
€276.51 (22.35% Upside)
Blogger Sentiment
Neutral
DE:9SI Sentiment 100%
Sector Average 63%
Sector Average 63%
Insider Transactions
Sold Shares
Worth €134.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.37%
12-Months-Change
Fundamentals
Return on Equity
0.43%
Trailing 12-Months
Asset Growth
-1.79%
Trailing 12-Months
Company Description
Standex International
Standex International Corporation (SXI) operates as a diversified global manufacturer and provider of products and services, catering to commercial and industrial markets across the United States and internationally. The company's operations are strategically organized into five key segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The Electronics division specializes in a wide array of sensors, including reed relays, fluid level, proximity, motion, flow, and HVAC condensate, along with custom electronic sensing solutions. It also delivers cutting-edge current sense and advanced planar transformer technologies, value-added assemblies, mechanical packaging, and bespoke wound transformers and inductors for both low and high-frequency applications. The Engraving segment offers mold texturizing, produces slush molding tools, provides roll engraving, and manufactures tooling for hygiene products and low observation vents. Additionally, it supplies project management and design services tailored for stealth aircraft, alongside process machinery for various industries. Within the Scientific segment, Standex develops and supplies temperature-controlled equipment, serving the medical, scientific, pharmaceutical, biotechnology, and broader industrial sectors. The Engineering Technologies segment is dedicated to providing comprehensive, customized net and near-net formed solutions for engineered components. These critical components are utilized across a wide spectrum of markets, including aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and both manned and unmanned space applications. Finally, the Specialty Solutions segment focuses on the manufacturing and distribution of refrigerated, heated, and dry merchandising display cases. It also provides custom fluid pump solutions and produces single and double-acting telescopic and piston rod hydraulic cylinders. Established in 1955, Standex International Corporation maintains its headquarters in Salem, New Hampshire.
9SI Company Deck
9SI Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed predominantly positive operational and financial momentum: strong top‑line growth (8.1% overall), record Electronics revenue, robust Aerospace & Defense expansion, accelerating new product sales (≈40% growth) and meaningful balance sheet improvement via the Federal divestiture and $62 million debt paydown. Offsetting items are modest: margin compression in parts of Electronics and Aerospace & Defense due to growth investments, a small revenue decline in Scientific tied to NIH cuts, organic softness in Hydraulics, and increased near‑term capex and operating cost investments. Overall, the positives (revenue growth, product pipeline, book‑to‑bill >1, debt reduction, improved EPS and FCF) materially outweigh the contained challenges and investments.View all DE:9SI earnings summaries9SI Stock 12 Month Forecast
Average Price Target
€276.51
▲(22.35% Upside)